Dracham Chinna Babu, Shankar Abhash, Madan Renu
Department of Radiotherapy and Oncology, PGIMER, Chandigarh, India.
Radiat Oncol J. 2018 Jun;36(2):85-94. doi: 10.3857/roj.2018.00290. Epub 2018 Jun 29.
Radiation-induced second malignancies (RISM) is one of the important late side effects of radiation therapy and has an impact on optimal treatment decision-making. Many factors contribute to the development of RISM such as age at radiation, dose and volume of irradiated area, type of irradiated organ and tissue, radiation technique and individual and family history of cancer. Exact mechanism of RISM is unknown. But nowadays, it is a growing concern in oncology because of the increased number of cancer survivors and efforts are being made to prevent or decrease the incidence of RISM. The primary search for articles was carried via Google Scholar and PubMed with keywords included 'radiation induced malignancies, second malignancies, and chemotherapy induced malignancies'. Additional papers were found through references from relevant articles. In this review article, we have discussed about the pathogenesis, factors contributing to RISM, screening and prevention strategies of RISM.
辐射诱发的第二原发恶性肿瘤(RISM)是放射治疗重要的晚期副作用之一,对最佳治疗决策有影响。许多因素促成了RISM的发生,如放疗时的年龄、照射区域的剂量和体积、受照器官和组织的类型、放疗技术以及个人和家族癌症史。RISM的确切机制尚不清楚。但如今,由于癌症幸存者数量的增加,它在肿瘤学领域日益受到关注,人们正在努力预防或降低RISM的发生率。通过谷歌学术和PubMed以“辐射诱发恶性肿瘤、第二原发恶性肿瘤和化疗诱发恶性肿瘤”为关键词进行了文章的初步检索。通过相关文章的参考文献找到了其他论文。在这篇综述文章中,我们讨论了RISM的发病机制、促成RISM的因素、筛查和预防策略。